Journals / International Journal of Innovative Research and Reviews / 2022 / Cilt: 6 - Sayı: 1

Nanotechnological Drug Release Systems in Oral Diseases: A Review

Pages
42–50
Publication Date
2022-07-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review study is aimed to explain the effects of nanotechnological drug delivery systems in the treatment of periodontal diseases and oral cancers, which will be examined under the title of oral diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nanotechnology is an interdisciplinary field on the focus of most researchescarried out in the field of health in recent years.
📊
Key Findings & Data:Nanotechnological drug release systems developed with nanotechnology have gained ground in many fields of medicine and have brought about in numerous advantages.
💡
Conclusion & Impact:This review study is aimed to explain the effects of nanotechnological drug delivery systems in the treatment of periodontal diseases and oral cancers, which will be examined under the title of oral diseases.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Dentistry · Drug release systems · Nanotechnology

Abstract

Nanotechnology is an interdisciplinary field on the focus of most researchescarried out in the field of health in recent years. Nanotechnological drug release systems developed with nanotechnology have gained ground in many fields of medicine and have brought about in numerous advantages. The small sizes and high surface areas of nano-scale particles provide chemically more reactive and superior electrical, magnetic, optical, biological, or mechanical properties compared to their macroscopic or microscopic counterparts. Thanks to their superior physicochemical and biological properties, nanotechnological drugs are involved in the diagnosis, prevention, and treatment of oral diseases such as dental caries, periodontal diseases, peri-implantitis, pulp, and periapical lesions, denture stomatitis, hyposalivation, oral cancer, and oral candidiasis. Nanotechnological drug delivery systems have taken an active role in the treatment of periodontal diseases and oral cancers, for they perform a long-term release in the mouth. This review study is aimed to explain the effects of nanotechnological drug delivery systems in the treatment of periodontal diseases and oral cancers, which will be examined under the title of oral diseases.

🔖

Cite This Article

GÜL, S. N. S., DİLSİZ, A. (2022). Nanotechnological Drug Release Systems in Oral Diseases: A Review. International Journal of Innovative Research and Reviews, Cilt: 6 - Sayı: 1, 42–50. https://ajindex.com/articles/767534

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Rudramurthy GR, Swamy MK. Potential applications of engineered nanoparticles in medicine and biology: an update. J Biol Inorg Chem(2018) 23(8):1185–1204. [2]Mercadante V, Scarpa E, Matteis V de, Rizzello L, Poma A. Engineering Polymeric Nanosystems against Oral Diseases. Molecules(2021) 26(8). [3]H RR, Dhamecha D, Jagwani S, Rao M, Jadhav K, Shaikh S, et al. Local drug delivery systems in the management of periodontitis: A scientific review. J Control Release(2019) 307:393–409. [4]Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol(2015) 15(1):30–44. [5]Petersen PE, Ogawa H. Strengthening the prevention of periodontaldisease: the WHO approach. J Periodontol(2005) 76(12):2187–2193. [6]Cafferata EA, Alvarez C, Diaz KT, Maureira M, Monasterio G, Gonzalez FE, et al. Multifunctional nanocarriers for the treatment of periodontitis: Immunomodulatory, antimicrobial, and regenerative strategies. Oral Dis(2019) 25(8):1866–1878. [7]Noble JM, Scarmeas N, Papapanou PN. Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature. Curr Neurol Neurosci Rep(2013) 13(10):384. [8]Bui FQ, Almeida-da-Silva CLC, Huynh B, Trinh A, Liu J, Woodward J, et al. Association between periodontal pathogens and systemic disease. Biomed J(2019) 42(1):27–35. [9]Chen X, Wu G, Feng Z, Dong Y, Zhou W, Li B, et al. Advanced biomaterials and their potential applications in the treatment of periodontal disease. Crit Rev Biotechnol(2016) 36(4):760–775. [10]Abou Neel EA, Bozec L, Perez RA, Kim HW, Knowles JC. Nanotechnology in dentistry: prevention, diagnosis, and therapy. Int J Nanomedicine(2015) 10:6371–6394. [11]Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm(2000) 50(1):83–99. [12]Pinon-Segundo E, Ganem-Quintanar A, Alonso-Perez V, Quintanar-Guerrero D.Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int J Pharm(2005) 294(1-2):217–232. [13]Hau H, Rohanizadeh R, Ghadiri M, Chrzanowski W. A mini-review on novel intraperiodontal pocket drug delivery materials for thetreatment of periodontal diseases. Drug Deliv Transl Res(2014) 4(3):295–301. [14]Pragati S, Ashok S, Kuldeep S. Recent advances in periodontal drug delivery systems. International Journal of Drug Delivery(2009) 1:1–14. [15]Kornman KS. Controlled-Release Local Delivery Antimicrobials in Periodontic